222482
Last Update Posted: 2007-08-09
Recruiting has ended
All Genders accepted | 21 Years-55 Years |
15 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Depakote ER in Borderline Personality Disorder
This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline Personality Symtoms are measured and side-effects are assessed.
Eligibility
Relevant conditions:
Borderline Personality Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov